Microsoft word - e_d_13

Description of the Item
Acetyl Salicylic acid tab IP (soluble)75mg Amoxycillin 500 mg with Clavulonic acid 125 mg 18-A Folic Acid & Ferrous sulphate Tablets (small) each film coated tablets containing dried ferrous sulphate IP 67mg (approx equivalent to 20 mg of ferrous iron) Folic acid IP 0.1 mg Injectables / I.V. Fluids
Aminophylline Injection IP 2.5% w/v (NLEM) Carboprost Promethamine Inj.USP 250 mg/ml Hydrocortisone sodium succinate for inj. IP 100mg Hydrocortisone /vial Inj. Heparin sodium salt(low molecular wt) 60 mg or equivalent Inj. Human Anti D (Rho(D) Immunoglobulin 300 mcg Lignocaine HCl 2% with Adrenaline (1:2,00,000) eachml contains Lignocaine HCL IP 21.3mg + adrenaline IP 0.005mg Lignocaine HCL and Dextrose Inj.IP (5% heavy) Metochlopramide Inj IP 2ml Each Ml contains Metochlopromide HCl IP Equivalent to Anhydrous Metoclopromide HCl 5mg Methyl Prednisolone Na succinate Inj 125mg I.V. Ciprofloxacin Injection 200mg/100ml I.P. I.V. Sodium Chloride 0.9% + Dextrose 5% inj I.V. Compound Na lactate inj. IP 540ml RL I.V. Multiple Electrolytes and Dextrose Inj Type 1 USP (Paed Sol with 5% Dextrose.) Mixture of Highly neutral insulin solution and Isophane suspension 100IU/ml Eye/ Ear/ Nasal Preparations
Ciprofloxacin Eye/Ear drops each ml containing Ciprofloxacin Hcl equivalent to Ciprofloxacin 0.3% Homotropine HBR2%, chlobutol 0.5%w/v eye drops Ofloxacin IP 0.3% + dexamethasone Sod. Phosphate eye drops equivalent to dexamethasone 0.1% Eye drops containing Tropicamide 0.8 %w/v, Phenylephine Hcl 5% w/v,Benzalkonium chloride 0.01% Viscoelastic(Hydroxy Propyl Methyl cellulose 2% prefilled syringes Wax dissolving ear drops containing parachloro benzene 2%, Benzocaine 2.5%, chlorobutol 5%, Turpentine 15% Antibiotic with steroid cream containing Gentamycin sulphate with hydrocortisone acetate Salbutamol 2.5 mg + Ipratropium Bromide 500mcg Respules Ointments/ Creams
Skin cream-Each gms. Containing Betamethasone Dipropionate USP 0.643mg.Gentamycin sulphate I.P. Eq. To Gentamycin Base 1mg + Tolnaftate USP 10mg, lodo – Chorohydroxyquinoline IP 10mg, Clotrimazole cream IP containing clotrimazole 1% w/w Ointment of Heparin and Benzlylnicotinate each gm containing heparin sodium IP 50 i.u. Benzyl Nicotinate 2mg Syrups/Suspensions/solutions
Lignocaine Hydrochloride Topical Solution USP 4% Oral Rehydration salts Citrate IP 27.5gms Concentrated vitamin ‘’A’’ solution 1 lac IU/ml Enema with glycerin 15% and sodium chloride 15% Annexure D
Name of the item
Inj. Pheniramine Maleate I.P. 22.75mg/ml Inj. Dexamethazone Sod. Phosphate I.P. 4mg/ml Catgut Chromic with needle (Atromatic) 1 Equine rabies Immunoglobulin 1000 IU inj. Inj. Hemocoagulase (each ml contains Aqueous sol. of Hemacoagulase isolated from Bothrops Jararaca /Atrox ICU) Soln. 0.2 Inj. Bupivacaine HCl Dextrose USP (Heavy) each ml contains Bupivacaine HCl IP equivalent to anhydrous upivacaine 5mg, dextrose IP 80mg Inj. Mersilk Non absorbable surgical suture USP 30mm ½ circle round body needle with sterilized body needle surgical needled size (braided silk black size 1, 3/0) Vicryl absorbable surgical suture(synthetic) sterilized surgical needled suture (coated polyglactin 910 violet) with 40mm ½ circle heavy round bodied needle 2-0,3-0 Prolene Non absorbable surgical suture USP sterilized surgical needled suture ( Monofilament poly propylene blue no. 1,1-0,2-0,3-0) Ethibond polyster green coated braided non absorbable suture sterile no. 2 & no. 5 Ethilon loop non absorbable surgical suture USP sterilized needle suture Monofilament polyamide black 10,150 cm loop

Source: http://www.dhsgoa.gov.in/documents/e_d.pdf

pointlomapdgroup.net

Promising Phase II Data For New Parkinson's Disease Drug Presented 22 Mar 2013 A new levodopa product (ODM-101) developed by Orion Corporation could improve the treatment of advanced Parkinson's disease patients. According to a Phase II study, presented yesterday at American Academy of Neurology's Annual Meeting in San Diego, ODM-101 significantly decreased daily OFF-time without increasing

Mise en page

Generics and Biosimilars Initiative JournalFor personal use only. Not to be reproduced without permission of the publisher ([email protected]). Generic and therapeutic orphans There are a few examples of private, e.g. Gates and Clinton Foundations; and public-not-for-profit Novartis Coartem malaria ini-tiative; that target infectious diseases seenmainly in the developing world [5],

Copyright © 2010-2014 Medical Articles